China · Delayed Price · Currency is CNY Novoray Statistics
Total Valuation
Novoray has a market cap or net worth of CNY 26.47 billion. The enterprise value is 26.03 billion.
| Market Cap | 26.47B |
| Enterprise Value | 26.03B |
Important Dates
The last earnings date was Wednesday, October 28, 2026.
| Earnings Date | Oct 28, 2026 |
| Ex-Dividend Date | Jun 10, 2026 |
Share Statistics
Novoray has 313.92 million shares outstanding. The number of shares has increased by 21.30% in one year.
| Current Share Class | 313.92M |
| Shares Outstanding | 313.92M |
| Shares Change (YoY) | +21.30% |
| Shares Change (QoQ) | -68.87% |
| Owned by Insiders (%) | 40.78% |
| Owned by Institutions (%) | 10.15% |
| Float | 112.86M |
Valuation Ratios
The trailing PE ratio is 80.56 and the forward PE ratio is 59.41.
| PE Ratio | 80.56 |
| Forward PE | 59.41 |
| PS Ratio | 19.77 |
| PB Ratio | 13.95 |
| P/TBV Ratio | 14.55 |
| P/FCF Ratio | 380.33 |
| P/OCF Ratio | 102.07 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 60.44, with an EV/FCF ratio of 373.96.
| EV / Earnings | 78.21 |
| EV / Sales | 19.44 |
| EV / EBITDA | 60.44 |
| EV / EBIT | 71.10 |
| EV / FCF | 373.96 |
Financial Position
The company has a current ratio of 4.48, with a Debt / Equity ratio of 0.41.
| Current Ratio | 4.48 |
| Quick Ratio | 4.00 |
| Debt / Equity | 0.41 |
| Debt / EBITDA | 1.82 |
| Debt / FCF | 11.24 |
| Interest Coverage | 39.76 |
Financial Efficiency
Return on equity (ROE) is 18.85% and return on invested capital (ROIC) is 23.24%.
| Return on Equity (ROE) | 18.85% |
| Return on Assets (ROA) | 8.55% |
| Return on Invested Capital (ROIC) | 23.24% |
| Return on Capital Employed (ROCE) | 13.63% |
| Weighted Average Cost of Capital (WACC) | 12.15% |
| Revenue Per Employee | 1.63M |
| Profits Per Employee | 405,828 |
| Employee Count | 820 |
| Asset Turnover | 0.50 |
| Inventory Turnover | 5.44 |
Taxes
In the past 12 months, Novoray has paid 46.80 million in taxes.
| Income Tax | 46.80M |
| Effective Tax Rate | 12.33% |
Stock Price Statistics
The stock price has increased by +83.58% in the last 52 weeks. The beta is 1.50, so Novoray's price volatility has been higher than the market average.
| Beta (5Y) | 1.50 |
| 52-Week Price Change | +83.58% |
| 50-Day Moving Average | 114.83 |
| 200-Day Moving Average | 98.10 |
| Relative Strength Index (RSI) | 39.36 |
| Average Volume (20 Days) | 10,125,579 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Novoray had revenue of CNY 1.34 billion and earned 332.78 million in profits. Earnings per share was 1.05.
| Revenue | 1.34B |
| Gross Profit | 511.54M |
| Operating Income | 366.05M |
| Pretax Income | 379.58M |
| Net Income | 332.78M |
| EBITDA | 427.92M |
| EBIT | 366.05M |
| Earnings Per Share (EPS) | 1.05 |
Balance Sheet
The company has 1.23 billion in cash and 782.10 million in debt, with a net cash position of 443.13 million or 1.41 per share.
| Cash & Cash Equivalents | 1.23B |
| Total Debt | 782.10M |
| Net Cash | 443.13M |
| Net Cash Per Share | 1.41 |
| Equity (Book Value) | 1.90B |
| Book Value Per Share | 6.04 |
| Working Capital | 1.56B |
Cash Flow
In the last 12 months, operating cash flow was 259.33 million and capital expenditures -189.74 million, giving a free cash flow of 69.60 million.
| Operating Cash Flow | 259.33M |
| Capital Expenditures | -189.74M |
| Depreciation & Amortization | 61.86M |
| Net Borrowing | 636.17M |
| Free Cash Flow | 69.60M |
| FCF Per Share | 0.22 |
Margins
Gross margin is 38.21%, with operating and profit margins of 27.34% and 24.85%.
| Gross Margin | 38.21% |
| Operating Margin | 27.34% |
| Pretax Margin | 28.35% |
| Profit Margin | 24.85% |
| EBITDA Margin | 31.96% |
| EBIT Margin | 27.34% |
| FCF Margin | 5.20% |
Dividends & Yields
This stock pays an annual dividend of 0.38, which amounts to a dividend yield of 0.46%.
| Dividend Per Share | 0.38 |
| Dividend Yield | 0.46% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 4 |
| Payout Ratio | 36.28% |
| FCF Payout Ratio | 173.48% |
| Buyback Yield | -21.30% |
| Shareholder Yield | -20.84% |
| Earnings Yield | 1.24% |
| FCF Yield | 0.26% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for Novoray is 116.15, which is 37.75% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 116.15 |
| Price Target Difference | 37.75% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | 31.68% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
The last stock split was on October 16, 2026. It was a forward split with a ratio of 1.3.
| Last Split Date | Oct 16, 2026 |
| Split Type | Forward |
| Split Ratio | 1.3 |
Scores
Novoray has an Altman Z-Score of 14.85 and a Piotroski F-Score of 4.
| Altman Z-Score | 14.85 |
| Piotroski F-Score | 4 |